Evidence map›Paper›PMID 37880584›Full record

ArticleBMC microbiology2023

Antimicrobial resistance profiles of salmonella spp. and escherichia coli isolated from fresh nile tilapia (oreochromis niloticus) fish marketed for human consumption.

Millicent T Mumbo, Evans N Nyaboga, Johnson K Kinyua, Edward K Muge, Scholastica G K Mathenge, Henry Rotich, Geoffrey Muriira, Bernard Njiraini, Joshua M Njiru

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Shiga Toxin-ProducingVeterinary sciences · 2026
    Review
  3. Article
  4. Article
  5. Microbiological Monitoring and Microbial Susceptibility ofAntibiotics (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Retrospective analysis of antimicrobial resistance ofFrontiers in veterinary science · 2025
    Article
  12. Article
  13. Antibacterial properties ofFrontiers in nutrition · 2025
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Millicent T MumboDepartment of Biochemistry, University of Nairobi, Nairobi, Kenya.
Evans N NyabogaDepartment of Biochemistry, University of Nairobi, Nairobi, Kenya. nyaboga@uonbi.ac.ke.
Johnson K KinyuaDepartment of Biochemistry, Jomo Kenyatta University of Agriculture and Technology (JKUAT), Nairobi, Kenya.
Edward K MugeDepartment of Biochemistry, University of Nairobi, Nairobi, Kenya.
Scholastica G K MathengeDepartment of Medical Laboratory Science, Kenyatta University, Nairobi, Kenya.
Henry RotichResearch and development Department, Kenya Bureau of Standards, Nairobi, Kenya.
Geoffrey MuriiraResearch and development Department, Kenya Bureau of Standards, Nairobi, Kenya.
Bernard NjirainiResearch and development Department, Kenya Bureau of Standards, Nairobi, Kenya.
Joshua M NjiruResearch and development Department, Kenya Bureau of Standards, Nairobi, Kenya.
Kenya Bureau of StandardsJomo Kenyatta University of Agriculture and Technology · KEUniversity of Nairobi · KEKenyatta University · KE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSalmonella spp. and pathogenic strains of Escherichia coli are among the major foodborne zoonotic pathogens. These bacterial pathogens cause human illnesses characterized by hemorrhagic colitis, vomiting, nausea, and other agent-related symptoms. The increasing occurrence of antimicrobial resistance in these pathogens is also a serious public health concern globally. Regular surveillance of phenotypes and genotypes of Salmonella spp. and Escherichia coli from animal-derived foods is necessary for effective reduction and control of these foodborne pathogens. This study was conducted to assess the occurrence, antimicrobial resistance, virulence genes and genetic diversity of Salmonella spp. and E. coli isolates from fresh Nile tilapia obtained from retail markets in Nairobi, Kenya.

methodsA total of 68 fresh Nile tilapia fish samples were collected from retail markets and used for isolation of Salmonella spp. and E. coli. Antimicrobial susceptibilities of the isolates weretested by Kirby-Bauer agar disc diffusion method. According to the antimicrobial resistance profiles, the multi-drug resistant isolates were identified by 16 S rRNA sequencing and phylogenetic analysis using the Bayesian inference method. The MDR Salmonella spp. and E. coli isolates were subjected to PCR-based screening for the detection virulence and antibiotic resistance genes.

resultsThe prevalence of contamination of the fish samples with Salmonella spp. and E.coli was 26.47% and 35.29% respectively. Overall phenotypic resistance among the Salmonella spp. ranged from 5.5% for ceftazidime, chloramphenicol, meropenem, nitrofurantoin and streptomycin and 22.2% for penicillin-G. For E. coli phenotypic resistance ranged from 4.2% for ceftazidime and chloramphenicol and 25% for rifampicin. Multi-drug resistance was observed in three Salmonella spp. and two E. coli isolates. Results of 16 S rRNA sequences, sequence alignment and phylogenic trees confirmed the identified MDR isolates as S. typhymurium WES-09, S. typhymurium MAK-22, S. typhimurium EMB-32 and E. coli MAK-26 and E. coli LAN-35. The presence of antibiotic-resistance genes belonging to β-lactamases, tetracycline, sulfonamide, trimethoprim and aminoglycosides-resistant genes were detected in all the identified MDR isolates.

conclusionsThe findings from this study indicate that Nile tilapia (Oreochromis niloticus) sold in retail markets can acts as reservoirs of Salmonella spp. and E. coli pathogens linked to human disease, some of which were multidrug resistance to critically important antimicrobials. Both microorganisms are of zoonotic significance and represent a significant public health risk to the society.

Indexed as

Anti-Bacterial AgentsCichlidsAnimalsBayes TheoremCeftazidimeChloramphenicolDrug Resistance, BacterialEscherichia coliHumansKenyaPhylogenySalmonellaAnti-Bacterial AgentsCeftazidimeChloramphenicolAntimicrobial resistanceEscherichia coliHealth riskMulti-drug resistantOreochromis niloticusS. typhimurium

Identifiers

PMID37880584
PMCPMC10601154
OpenAlexW4387948936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.